Toggle menu

CoviTact

Start date:
14/12/2020
Main trial site:
Royal Infirmary of Edinburgh

The CoviTact trial aims to collect saliva samples from COVID positive and negative patients in order to evaluate a new assay developed to detect the presence of SARS-COVID 2.

Samples are collected as part of ongoing studies and will be tested using the novel assay and via PCR.

Research Team

Julia Grahamslaw

Lead Research Nurse

More EMERGE Trials

Assisting in identifying patients with Humeral shaft fractures in the ED by screening.

Giving patient information sheets to introduce the study, so patient has had adequate time to read and make decision about going into the trial before going to the fracture clinic.

Read more

HU-FIX Trial

The RECOVERY Trial

Randomised Evaluation of COVID-19 Therapy

Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.

Read more

IONA Study

Identification of Novel Psychoactive Substances (IONA)